HRT Financial’s Japer Therapeutics Warrants JSPRW Stock Holding History

HRT Financial’s Portfolio JSPRW Stock Details JSPRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-22,524	Closed	–	–	2830
2022 Q4	$0	Sell	22,524 -6,940	-24%	-$305	﹤0.01%	2809
2022 Q3	$2K	Sell	29,464 -4,852	-14%	-$424	﹤0.01%	2647
2022 Q2	$3K	Sell	34,316 -2,729	-7%	-$530	﹤0.01%	2776
2022 Q1	$10K	Hold	37,045	–	–	﹤0.01%	2898
2021 Q4	$54K	Hold	37,045	–	–	﹤0.01%	2834
2021 Q3	$54K	Sell	37,045 -23,758	-39%	-$25.4K	﹤0.01%	3033
2021 Q2	$70K	Buy	60,803 +20,276	+50%	+$19.2K	﹤0.01%	2647
2021 Q1	$33K	Hold	40,527	–	–	﹤0.01%	2571
2020 Q4	$58K	Hold	40,527	–	–	﹤0.01%	1684
2020 Q3	$50K	Buy	+40,527	New	+$41K	﹤0.01%	1673

Other funds holding JSPRW

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Zazove Associates Incline Village, Nevada $1.22B AUM 1.91% 1-Year Est. Return

EPM

Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HRT Financial's JSPRW Position: Q1 2023 in Review

HRT Financial sold out of Japer Therapeutics Warrants (JSPRW) in Q1 2023, closing a stake of 22,524 shares.

HRT Financial first reported a position in JSPRW in Q3 2020 and held it in 10 quarters. The position peaked at $70K in Q2 2021. 10 funds tracked by Wall St. Rank hold JSPRW as of Q1 2023.

HRT Financial reported no remaining Japer Therapeutics Warrants position as of Q1 2023 after selling out during the quarter.
HRT Financial sold 22,524 Japer Therapeutics Warrants shares in Q1 2023.
HRT Financial first reported a position in Japer Therapeutics Warrants in Q3 2020 and held it in 10 quarters.
HRT Financial's Japer Therapeutics Warrants position peaked at $70K in Q2 2021.
10 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q1 2023.

Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.